Subspecialty	Gastroenterology , Liver Transplantation
Clinical Interests	Liver Disease
	Hepatobiliary Disease
	Intestinal Transplantation
	Live Donor Liver Transplant
	Liver Transplant
	Nutrition in Liver Disease
	Viral Hepatitis
Languages	English
	Spanish
Gender	Male
E-mail	thomas.schiano@mountsinai.org
Education and Training	MD, Universidad Del Noreste
	Residency, Internal Medicine, Maimonides Medical Center
	Fellowship, Clinical Nutrition, Memorial Sloan-Kettering
	Fellowship, Liver Disease-Trans, Mount Sinai Hospital
	Fellowship, Gastroenterology, Temple University Hospital
Awards	2008 - 2009 Super Doctors NY Times Magazine
	2008 - 2009 Best Doctors New York Magazine
	2008 Castle-Connolly America's Top Doctors
	2006 Manhattan Chapter Triangle Award Transplant Physicians TRIO (Transplant Recipients International Organization)
	1995 Sol Sherry Award Excellence in Basic Research Temple University Hospital
	1991 Award for Excellence Outstanding 3rd Year Medical Resident Maimonides Medical Center
	1990 Award for Excellence Outstanding 2nd Year Medical Resident Maimonides Medical Center
	1989 Award for Excellence Outstanding 1st Year Medical Resident Maimonides Medical Center

Dr. Thomas D. Schiano has a clinical background in hepatology, gastroenterology and clinical nutrition. He has expertise in the management of persons with cirrhosis and other acute/chronic liver diseases, and in caring for patients prior to and after liver transplantation. Dr. Schiano has varied clinical research interests including herbal treatments of liver disease, nutritional aspects of liver disease, recurrence of disease post liver transplantation, living donor liver transplantation, and management of the complications of cirrhosis. In addition, he is involved in the care of patients pre- and post-intestinal transplant.

Dr. Schiano is a UNOS-certified Liver Transplant physician, and is board certified in internal medicine, clinical nutrition, and gastroenterology.

Dr. Schiano is Medical Director of Adult Liver Transplantation and Director of Clinical Hepatology at the Recanati/Miller Transplantation Institute.

Education and Training	MD, Universidad Del Noreste
	Residency, Internal Medicine, Maimonides Medical Center
	Fellowship, Clinical Nutrition, Memorial Sloan-Kettering
	Fellowship, Liver Disease-Trans, Mount Sinai Hospital
	Fellowship, Gastroenterology, Temple University Hospital
Board Certification	Gastroenterology

Subspecialty	Gastroenterology , Liver Transplantation
Clinical Interests	Liver Disease
	Hepatobiliary Disease
	Intestinal Transplantation
	Live Donor Liver Transplant
	Liver Transplant
	Nutrition in Liver Disease
	Viral Hepatitis
Languages	English
	Spanish
Board Certification	Gastroenterology

Research
Liver transplantation, living donor liver transplantation, herbal and drug hepatotoxicity, nutrition, cirrhosis, intestinal transplantation, recurrence of disease post-liver transplantation, treatment of viral hepatitis post-liver transplantation, herbal and alternative treatments of chronic liver disease, complications of cirrhosis, portal hypertension, cholestasis associated with TPN.

Harpaz N, Schiano TD, Ruf AE, Sauter BV, Tao Y, Fishbein TM, Shukla D. Early and frequent histological re-currence of Crohn's disease in small intestinal allografts. Transplantation 2005; 80: 1667-1670.

Schiano TD, Gutierrez JA, Walewski JL, Fiel MI, Fernandez EJ, Branch AD, Nelson C, Bodenheimer H, Thung S, Chung RT, Schwartz ME, Cheng B. HCV levels rise quickly in liver transplant patients with live donors, persistent ALT elevations often follow. Hepatology 2005; 42: 1420-1428.

Carmiel-Haggai M, Fiel MI, Gaddipati HC, Abittan C, Schiano TD, Roayaie S, Emre S, Gondolesi G, Schwartz M, Hossain S. Frequency of hepatitis C recurrence and factors affecting patient outcome after re-transplantation for recurrent hepatitis C. Liver Transpl 2005; 11: 1567-1573.

Poonawala Khapra A, Agarwal K, Fiel MI, Schiano TD, Hossain S, Emre S, Kontorinis N. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using hepatitis C+ allografts. Liver Transpl 2006; 12: 1496-1503.

Schiano TD, Charlton M, Younossi Z, Galun E, Pruett T, Andrews J, Eren R, Dagan S, Graham N, Williams PV, Tur-Kaspa R. Monoclonal antibody HCV-AbxTL68 in patients undergoing liver transplantation for HCV: Results of a Phase 2 randomized study. Liver Transpl 2006; 12: 1381-1389.